Alexander Nowak analyst CRAIG HALLUM

Currently out of the existing stock ratings of Alexander Nowak, 83 are a BUY (84.69%), 13 are a HOLD (13.27%), 2 are a SELL (2.04%).

Alexander Nowak

Work Performance Price Targets & Ratings Chart

Analyst Alexander Nowak works at CRAIG HALLUM with a stock forecast success ratio of 45.66% fulfilled within 143.24 days on average.

Alexander Nowak’s has documented 216 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DMAC, DiaMedica Therapeutics at 24-Apr-2024.

Wall Street Analyst Alexander Nowak

Analyst best performing recommendations are on DRIO (DARIOHEALTH CORP).
The best stock recommendation documented was for CDNA (CAREDX) at 11/9/2023. The price target of $9 was fulfilled within 6 days with a profit of $1.79 (24.83%) receiving and performance score of 41.38.

Average potential price target upside

CDNA Caredx CELC Celcuity LLC EXAS EXACT Sciences INFU InfuSystems Holdings NEO NeoGenomics NTRA Natera QDEL Quidel SDC SmileDirectClub TECH Bio-Techne Corp TNDM Tandem Diabetes Care DRIO DarioHealth Corp HTGM HTG Molecular Diagnostics SIEN Sientra DMAC DiaMedica Therapeutics BVS Bioventus ALIM Alimera Sciences CVRX CVRx

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

9

$1.02 (12.78%)

8

5 months 16 days ago

8/13 (61.54%)

$1.79 (24.83%)

89

Buy

10

$2.02 (25.31%)

10

5 months 16 days ago

3/5 (60%)

$2.79 (38.70%)

43

Buy

12

$4.02 (50.38%)

8 months 10 days ago

3/11 (27.27%)

$2.34 (24.22%)

68

Hold

8 months 16 days ago

6/6 (100%)

$5.95 (12.13%)

165

Hold

25

11 months 14 days ago

1/5 (20%)

$8.18 (48.63%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Alexander Nowak is most bullish on?

Potential upside of $25.5 has been obtained for NTRA (NATERA)

Which stock is Alexander Nowak is most reserved on?

Potential downside of -$0.12 has been obtained for TNDM (TANDEM DIABETES CARE)

What Year was the first public recommendation made by Alexander Nowak?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?